Purpose: To evaluate the effect of dopaminergic medication and deep brain stimulation on ocular function in Parkinson's disease (PD) and to measure vision-related quality of life in subjects with PD.
Design: Prospective, comparative case series.
Participants And Controls: Twenty-seven PD and 16 control subjects were recruited.